| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 13.15% | +10.5% | $18,692,393 | +$1,791,458 | 1,635,380 | +10.6% | Federated Hermes, Inc. | 30 Sep 2025 |
| ALGER ASSOCIATES INC | 13.1% | -1.5% | $24,514,005 | +$234,270 | 1,634,267 | +0.96% | Alger Associates, Inc. | 30 Sep 2025 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 9.99% | 0% | $13,378,307 | +$6,618,184 | 1,268,086 | +97.9% | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 30 Jun 2025 |
| Affinity Asset Advisors, LLC | 6.9% | $16,437,344 | 862,400 | Affinity Asset Advisors, LLC | 17 Dec 2025 | |||
| JANUS HENDERSON GROUP PLC | 9.9% | 0% | $6,936,720 | 657,509 | 0% | JANUS HENDERSON GROUP PLC | 30 Jun 2025 | |
| Ikarian Capital, LLC | 4.99% | -45.1% | $6,516,387 | +$89,063 | 617,667 | +1.4% | Ikarian Capital, LLC | 30 Jun 2025 |
| ORBIMED ADVISORS LLC | 8% | $3,763,800 | 510,000 | ORBIMED ADVISORS LLC | 31 Dec 2024 | |||
| Oliveira Steven Michael | 6.76% | $3,190,197 | 432,276 | Nemean Asset Management, LLC | 20 Nov 2024 | |||
| PERCEPTIVE ADVISORS LLC | 2.5% | $1,209,840 | 163,935 | Perceptive Advisors LLC | 31 Dec 2024 | |||
| BIOTECHNOLOGY VALUE FUND L P | 0.5% | -94.9% | $980,250 | -$8,674,080 | 65,350 | -89.8% | BVF PARTNERS L P/IL | 30 Sep 2025 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.8% | -86.7% | $567,495 | -$369,187 | 53,791 | -39.4% | Boothbay Fund Management, LLC | 30 Jun 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 10,343,866 | $155,080,846 | +$6,727,909 | $15 | 42 |
| 2025 Q2 | 9,809,779 | $127,063,335 | +$62,289,077 | $12.93 | 33 |
| 2025 Q1 | 5,034,489 | $39,316,245 | +$4,704,465 | $7.76 | 29 |
| 2024 Q4 | 4,275,821 | $97,104,372 | +$81,936,549 | $22.71 | 26 |
| 2024 Q3 | 736,630 | $4,120,236 | +$4,082,162 | $5.59 | 23 |